Updated 6 Year Follow-Up Of The Prima Study Confirms The Benefit Of 2-Year Rituximab Maintenance In Follicular Lymphoma Patients Responding To Frontline ImmunochemotherapyJohn F. Seymour,Pierre Feugier,Fritz Offner,Armando López-Guillermo,David Belada,Luc Xerri,Reda Bouabdallah,John Catalano,Brice Pauline,Dolores Caballero,Corinne Haioun,Lars Møller Pedersen,Alain Delmer,David Simpson,Sirpa Leppa,Pierre Soubeyran,Anton Hagenbeek,Olivier Casasnovas,Tanin Intragumtornchai,Christophe Fermé,Maria Gomes da Silva,Catherine Sebban,Andrew Lister,Jane Estell,Gustavo Milone,Anne Sonet,Bertrand Coiffier,Hervé TillyBLOOD(2013)引用 69|浏览17暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要